Project

Poly(2-oxazoline) production

Acronym
PAOx plant
Duration
15 January 2015 → 31 December 2017
Funding
Regional and community funding: Industrial Research Fund
Research disciplines
  • Medical and health sciences
    • Biomarker discovery and evaluation
    • Drug discovery and development
    • Medicinal products
    • Pharmaceutics
    • Pharmacognosy and phytochemistry
    • Pharmacology
    • Pharmacotherapy
    • Toxicology and toxinology
    • Other pharmaceutical sciences
Keywords
Poly(2-oxazoline)
 
Project description

This Stepstone project will provide us with the sufficient timeframe and resources to scale-up PAOx production and to prepare the business-model, leading to successful validation and robust commercialization of high-quality, highly defined functional PAOx under the tradename Ultroxa®.